PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 46.71
+0.52 (1.13%)
At close: Feb 12, 2026
SHE:301230 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 36.59 | 17.08 | 37.62 | 67.18 | 73.58 | 48.69 |
Depreciation & Amortization | 48.81 | 48.81 | 35.53 | 28.4 | 24.07 | 11.76 |
Other Amortization | 28.83 | 28.83 | 13 | 9.26 | 2.68 | 4.17 |
Loss (Gain) From Sale of Assets | - | - | -0.01 | - | -0.05 | - |
Asset Writedown & Restructuring Costs | 0.29 | 0.29 | 0.71 | 0.07 | 2.55 | 2.7 |
Loss (Gain) From Sale of Investments | -8.41 | -8.41 | -6.21 | -0.5 | -1.8 | -1.67 |
Provision & Write-off of Bad Debts | 1.27 | 1.27 | 0.3 | -0.31 | 2.46 | -0.8 |
Other Operating Activities | 45.73 | 3.83 | 18.13 | -0.77 | 4.25 | 7.37 |
Change in Accounts Receivable | 7.11 | 7.11 | -51.12 | -8.99 | -60.22 | 7.55 |
Change in Inventory | -4.37 | -4.37 | -18.29 | -6.37 | 13.39 | -26.14 |
Change in Accounts Payable | 7.25 | 7.25 | -7.84 | -1.77 | 33.55 | -4.21 |
Change in Other Net Operating Assets | - | - | 5.4 | 11.45 | 11.45 | 6.05 |
Operating Cash Flow | 142.27 | 80.86 | 20.86 | 99.29 | 105.12 | 54.45 |
Operating Cash Flow Growth | - | 287.68% | -78.99% | -5.55% | 93.06% | 33.69% |
Capital Expenditures | -68.69 | -109.4 | -248.27 | -123.97 | -92.12 | -33.51 |
Sale of Property, Plant & Equipment | 0.1 | 0.15 | 0.01 | - | 0.06 | 0.02 |
Investment in Securities | -15.63 | 61 | -339.97 | -7.99 | 1.8 | 51.44 |
Other Investing Activities | -1.28 | 3.44 | 5.94 | 0.15 | - | - |
Investing Cash Flow | -85.5 | -44.82 | -582.28 | -131.81 | -90.25 | 17.95 |
Short-Term Debt Issued | - | 19.65 | 15.91 | 12.24 | 26.24 | 57.48 |
Total Debt Issued | 25.66 | 19.65 | 15.91 | 12.24 | 26.24 | 57.48 |
Short-Term Debt Repaid | - | -25.56 | -10 | -24.55 | -26.56 | -60.36 |
Long-Term Debt Repaid | - | -29.34 | -23.28 | -14.28 | -9.39 | - |
Total Debt Repaid | -49.31 | -54.91 | -33.28 | -38.84 | -35.94 | -60.36 |
Net Debt Issued (Repaid) | -23.65 | -35.25 | -17.37 | -26.59 | -9.7 | -2.88 |
Issuance of Common Stock | - | - | - | 710 | - | 65.99 |
Common Dividends Paid | -59.53 | -49.27 | -38.82 | -0.78 | -0.78 | -58.87 |
Dividends Paid | -59.53 | -49.27 | -38.82 | -0.78 | -0.78 | -58.87 |
Other Financing Activities | 0.54 | -53.08 | - | - | - | - |
Financing Cash Flow | -82.64 | -137.61 | -56.19 | 682.62 | -10.48 | 4.25 |
Foreign Exchange Rate Adjustments | 4.28 | 4.82 | -0.54 | 7.78 | -2.11 | -6.15 |
Net Cash Flow | -21.59 | -96.75 | -618.15 | 657.89 | 2.28 | 70.5 |
Free Cash Flow | 73.58 | -28.54 | -227.41 | -24.67 | 13.01 | 20.94 |
Free Cash Flow Growth | - | - | - | - | -37.90% | 207.82% |
Free Cash Flow Margin | 11.02% | -5.24% | -46.44% | -5.15% | 2.90% | 7.40% |
Free Cash Flow Per Share | 0.51 | -0.20 | -1.63 | -0.22 | 0.12 | 0.20 |
Cash Income Tax Paid | 3.81 | 5.17 | -2.53 | -4.43 | 11.2 | -1.16 |
Levered Free Cash Flow | -5.71 | -136.91 | -130.96 | -48.28 | -7.85 | 7.13 |
Unlevered Free Cash Flow | -0.37 | -131.11 | -127.54 | -45.29 | -6.26 | 7.89 |
Change in Working Capital | -10.84 | -10.84 | -78.22 | -4.02 | -2.61 | -17.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.